findmyKOL
Clinical trialNCT04922593CompletedPhase 1Interventional

Relative Bioavailability of LY03010 Compared to Listed Drug

SponsorLuye Pharma Group Ltd.Enrollment281Antipsychotic AgentsCentral Nervous System DepressantsMental DisordersMolecular Mechanisms of Pharmacological ActionMood DisordersNeurotransmitter Agents+6 more conditions
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Collaborative Neuroscience Network, Inc.

    Garden Grove, California, United States

  • Synergy San Diego

    Lemon Grove, California, United States

  • Cns Network, Llc

    Torrance, California, United States

  • Innovative Clinical Research, Inc.

    Miami Lakes, Florida, United States

  • Uptown Research Institute, Llc

    Chicago, Illinois, United States

  • Hassman Research Institute

    Berlin, New Jersey, United States

  • Hassman Research Institute

    Marlton, New Jersey, United States

  • Insite Clinical Research, Llc

    DeSoto, Texas, United States

  • Pillar Clinical Research, Llc

    Richardson, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
13 Jan 2021
Primary completion
15 Mar 2022
Completion
15 Apr 2022
Last update posted
25 Apr 2023
Registered enrollment
281
Registry id
NCT04922593

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.